Published in Am J Transplant on March 01, 2005
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest (2008) 2.73
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology (2010) 1.39
Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97
Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes. Rev Diabet Stud (2010) 0.96
Tolerance in clinical transplantation: progress, challenge or just a dream? Langenbecks Arch Surg (2011) 0.88
Immune Monitoring as Prerequisite for Transplantation Tolerance Trials. Clin Exp Immunol (2017) 0.84
Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant (2008) 0.83
Clinical transplantation tolerance. Semin Immunopathol (2011) 0.83
Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation. World J Gastroenterol (2013) 0.79
Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. Yonsei Med J (2009) 0.78
Expression of alpha smooth muscle actin in living donor liver transplant recipients. World J Gastroenterol (2014) 0.76
Chimerism and liver transplant tolerance. J Hepatol (2008) 0.76
Tolerance in liver transplantation: Biomarkers and clinical relevance. World J Gastroenterol (2016) 0.75
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A (2006) 5.41
Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 3.62
Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell (2005) 3.52
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology (2014) 3.29
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity (2012) 3.21
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant (2005) 3.07
Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA (2012) 2.85
A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant (2005) 2.74
Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab (2011) 2.48
Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med (2008) 2.41
Penile reconstruction: is the radial forearm flap really the standard technique? Plast Reconstr Surg (2009) 2.40
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol (2005) 2.26
When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg (2014) 2.23
Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant (2005) 2.04
Glutamate is a positive autocrine signal for glucagon release. Cell Metab (2008) 2.01
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology (2011) 1.94
The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation (2008) 1.83
Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation (2008) 1.80
Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes (2011) 1.77
Raccoon rabies virus variant transmission through solid organ transplantation. JAMA (2013) 1.71
Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes (2010) 1.69
Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl (2009) 1.67
Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation (2008) 1.66
Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl (2009) 1.65
Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization. Am J Transplant (2003) 1.64
Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med (2011) 1.62
Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol (2005) 1.62
Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Liver Transpl (2008) 1.59
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology (2012) 1.56
MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging (2010) 1.56
Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Biophys Res Commun (2007) 1.54
Transplantation of the abdominal wall. Lancet (2003) 1.51
Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation (2013) 1.50
Second MTP joint instability: grading of the deformity and description of surgical repair of capsular insufficiency. Phys Sportsmed (2011) 1.46
Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45
Heterogeneity of cognitive trajectories in diverse older persons. Psychol Aging (2010) 1.44
Consumption of dietary supplements in a liver transplant population. Liver Transpl (2004) 1.43
Segmental xanthomatosis of the small intestine. A case report and review of the literature. Hum Pathol (2008) 1.43
Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation (2002) 1.42
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl (2004) 1.42
Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol (2003) 1.42
Infrahepatic vena cavocavostomy, a modification of the piggyback technique for liver transplantation. Am Surg (2009) 1.40
Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium. Transplantation (2005) 1.40
Living-related intestinal transplantation for a patient with hypoganglionosis. Pediatr Transplant (2006) 1.39
ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal (2011) 1.38
Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation (2006) 1.37
ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A (2010) 1.35
100 multivisceral transplants at a single center. Ann Surg (2005) 1.34
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation (2002) 1.32
Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant (2005) 1.32
A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation (2004) 1.30
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation (2003) 1.28
Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant (2007) 1.26
Endocrine cell clustering during human pancreas development. J Histochem Cytochem (2009) 1.26
Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation (2007) 1.26
Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol (2007) 1.26